Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
Letter: Praise for SAPHO Syndrome Article
After reading your article on SAPHO, I may get a better treatment plan for my patient; thanks for drawing the attention of American College of Rheumatology members to an obscure condition that can vex patients and clinicians
ACR/ARHP Annual Meeting 2012: Cyclophosphamide and Rituximab Both Viable Treatment Options for ANCA-Associated Vasculitis
Rituximab established as the drug of choice in patients with severe disease relapse, though cyclophosphamide may still play an important role for some patients, say rheumatologists
ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis
A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.
New Hydrogel May Offer Promising Osteoarthritis Treatment
A new hydrogel that can be stretched and is self-healing might become an effective ligament repair option in osteoarthritis (OA).
Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
A Spotlight on IgG4-Related Disease
What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)
ACR/ARHP Annual Meeting 2012: Late-Breaking Abstracts Bring Newer Research to the Forefront
Studies addressing rheumatoid arthritis (RA) flares, a potential new drug for psoriatic arthritis, and a novel agent in the treatment of active RA are among the highlights
- « Previous Page
- 1
- …
- 299
- 300
- 301
- 302
- 303
- …
- 345
- Next Page »